Clinical Trial Update: A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy [Phase 1]

View source ↗

Summary

This entry reports a Phase I trial evaluating S-1 with irinotecan and oxaliplatin for advanced gastrointestinal cancers, including colorectal and gastric malign…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Colorectal Neoplasm, Gastric Neoplasm | Phase 1 | Status: UNKNOWN